Skip to main content

Table 4 Histone variant H2A.Z at enhancers

From: The histone variant H2A.Z in gene regulation

TFs

Effects of H2A.Z depletion

References

AhR

Reduced induction upon treatment

[88]

AP-1

Upregulation

[72]

AR

Reduced induction upon treatment

[51, 52, 59, 119]

ER

Lack of induction upon treatment

[50, 54, 87, 118]

FoxA2

n.d.

[237]

GR

n.d.

[69, 86]

ISGF3

Increased induction upon treatment

[73]

Muscle differentiationb

n.d.

[56]

Myc

n.d.

[77]

p53

Upregulationa

[49, 134, 217]

PU.1

n.d.

[120]

∆Np63α

Upregulation

[134, 217]

RARγ

n.d.

[71]

RBPJ

Upregulation

[57]

SMAD3

Downregulation

[161]

  1. aVariable based on the cell type; bthe TFs have not been investigated; however, H2A.Z localizes at enhancers
  2. The table lists only the cases described in mouse and human. Enhancers are defined as those sites that are bound by signal-specific transcription factors (TFs). AhR aryl hydrocarbon receptor (also known as dioxin receptor), AP-1 activator protein-1, AR androgen receptor, ER estrogen receptor, FoxA2 forkhead box protein A2, GR glucocorticoid receptor, ISGF3 interferon-stimulated gene factor complex 3 (IRF9 and phosphorylated STAT1 and STAT2), RARγ retinoic acid receptor γ, n.d. not determined